@kmartfit's TRT fertility claims need serious context
Quick answer
Exogenous testosterone suppresses the HPG axis and reduces spermatogenesis in most men, but co-administration of HCG or enclomiphene can partially or fully preserve sperm production in many cases by maintaining gonadotropin signaling. The creator's claim that he remains fertile after five years on TRT with enclomiphene is plausible but not generalizable, as individual response varies and long-term data on enclomiphene co-administration with TRT remains limited. Men concerned about fertility should consult a urologist or reproductive endocrinologist before starting TRT, and sperm banking remains the most reliable protective option.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @kmartfit actually say?
The creator claims that TRT will not permanently kill your fertility, as long as your doctor adds HCG or "an inclomethine" (he means enclomiphene, a selective estrogen receptor modulator) to your protocol. He says he has been on TRT for five years and remains "fully fertile" because of enclomiphene. He then pitches a referral to his personal doctor in the comments.
The fertility preservation claim is worth taking seriously. The doctor referral pitch, however, is a different story and deserves its own scrutiny. These are two separate things and conflating them is part of what makes this video slippery.
Does the science back this up?
Partially, yes. The core claim that fertility can often be preserved or restored during TRT is supported by clinical evidence, but the phrase "keeps your fertility at 100%" is not something any honest doctor would promise a patient.
Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, sharply reducing LH and FSH. Without those signals, the testes stop producing sperm. HCG mimics LH and can maintain intratesticular testosterone and spermatogenesis during TRT. A 2005 study by Coviello et al. in the Journal of Clinical Endocrinology and Metabolism showed that low-dose HCG (125-500 IU every other day) maintained intratesticular testosterone in men on exogenous testosterone. Enclomiphene, which blocks estrogen receptors in the hypothalamus, can stimulate endogenous LH and FSH production. A 2013 randomized trial by Kim et al. in BJU International found enclomiphene raised testosterone and gonadotropins in hypogonadal men without suppressing sperm production. So the tools he describes are real. The "100%" guarantee is not.
What did they get wrong (or right)?
He got the general concept right: adjunct therapy with HCG or enclomiphene is a legitimate strategy used by reproductive endocrinologists and urologists to preserve fertility in men on TRT. That is not fringe advice. It is in clinical practice guidelines.
What he got wrong is the certainty. Saying these treatments keep fertility "at 100%" is misleading. Response to HCG and enclomiphene varies significantly between individuals. Some men experience incomplete spermatogenesis recovery even with adjunct therapy, particularly after prolonged TRT use. A 2020 review by Patel et al. in Therapeutic Advances in Urology noted that recovery of spermatogenesis is not guaranteed and can take 12 to 24 months after stopping TRT even with assisted recovery protocols.
He also mispronounces and misspells "enclomiphene" as "inclomethine," which is a small thing but matters when 69,000 people are watching and might search that term. More concerning is the comment-section doctor referral. That structure, where a creator funnels followers to a specific provider for commission or affiliation, raises real questions about conflicts of interest that viewers deserve to know about.
What should you actually know?
If you are on TRT and want biological children, this is a real conversation to have with a urologist or reproductive endocrinologist before you start treatment, not after. HCG co-administration and enclomiphene are both used clinically to preserve sperm production, but neither is a guaranteed solution for every man.
- HCG maintains intratesticular testosterone and has the strongest evidence base for fertility preservation during TRT.
- Enclomiphene (not "inclomethine") is an active isomer of clomiphene citrate and can stimulate the HPG axis without direct testosterone administration, making it an alternative to TRT for some men who want to preserve fertility entirely.
- Men who have used TRT for years without fertility preservation may face longer or incomplete recovery windows.
- Sperm banking before starting TRT is the most reliable insurance policy for men who want biological children in the future.
- Any provider recommending a specific protocol should be disclosing financial relationships with the platforms or doctors they refer to.
Bottom line
The creator is not wrong that fertility preservation during TRT is achievable for many men with the right protocol. The problem is the absolute confidence, the sloppy drug name, and the referral funnel. Use this video as a starting point for a real conversation with a licensed provider, not as a treatment plan.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @kmartfit's TRT fertility claims need serious context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
@kmartfit's TRT fertility claims need serious context should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Exogenous testosterone suppresses the HPG axis and reduces spermatogenesis in most men, but co-administration of HCG or enclomiphene can partially or fully preserve sperm production in many cases by maintaining gonadotropin signaling.
FormBlends verdict
Exogenous testosterone suppresses the HPG axis and reduces spermatogenesis in most men, but co-administration of HCG or enclomiphene can partially or fully preserve sperm production in many cases by maintaining gonadotropin signaling. The creator's claim that he remains fertile after five years on TRT with enclomiphene is plausible but not generalizable, as individual response varies and long-term data on enclomiphene co-administration with TRT remains limited. Men concerned about fertility should consult a urologist or reproductive endocrinologist before starting TRT, and sperm banking remains the most reliable protective option.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Exogenous testosterone suppresses the HPG axis and reduces spermatogenesis in most men, but co-administration of HCG or enclomiphene can partially or fully preserve sperm production in many cases by maintaining gonadotropin signaling. The creator's claim that he remains fertile after five years on TRT with enclomiphene is plausible but not generalizable, as individual response varies and long-term data on enclomiphene co-administration with TRT remains limited. Men concerned about fertility should consult a urologist or reproductive endocrinologist before starting TRT, and sperm banking remains the most reliable protective option.
- Exogenous testosterone suppresses LH and FSH, reducing spermatogenesis in most men, this is well-established physiology not a fringe concern.
- HCG co-administration at low doses (125-500 IU every other day) was shown to maintain intratesticular testosterone in men on exogenous testosterone in a 2005 Coviello et al. study in JCEM.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Exogenous testosterone suppresses LH and FSH, reducing spermatogenesis in most men, this is well-established physiology not a fringe concern.
- HCG co-administration at low doses (125-500 IU every other day) was shown to maintain intratesticular testosterone in men on exogenous testosterone in a 2005 Coviello et al. study in JCEM.
- Enclomiphene stimulates endogenous LH and FSH by blocking estrogen receptors in the hypothalamus. A 2013 Kim et al. trial in BJU International showed it raised gonadotropins without suppressing sperm production.
- Fertility recovery after TRT is not guaranteed even with adjunct therapy. A 2020 Patel et al. review found recovery can take 12 to 24 months and may be incomplete in some men.
- Sperm banking before starting TRT is the most reliable way to protect future fertility options, and no adjunct drug protocol replaces that as a guarantee.
- The drug is called enclomiphene, not inclomethine. Patients searching the wrong term will not find accurate clinical information.
- Any creator referring followers to a specific provider in the comments should disclose any financial or affiliate relationship with that provider. This video does not do that.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
KMART · TikTok creator
69.5K views on this video
Fertility on TRT #Trt #trtgains #trt101 #trtfamily #trttransformation #trtshots #trtshot #trtforlife #trtdays #trtcommunity #trtbeforeandafter #trtlife #trtgainz #trtformen #trtworld #trtnation #l
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by KMART, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.